Cerevel Therapeutics Holdings Price on July 21, 2024

If you're considering investing in Cerevel Stock, it is important to understand the factors that can impact its price. We have found twenty-one technical indicators for Cerevel Therapeutics Holdings, which you can use to evaluate the volatility of the firm. Please confirm Cerevel Therapeutics' Downside Deviation of 1.05, mean deviation of 0.7719, and Risk Adjusted Performance of 0.0551 to double-check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Cerevel Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
CERE
Based on monthly moving average Cerevel Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cerevel Therapeutics by adding Cerevel Therapeutics to a well-diversified portfolio.

Related Headline

IGM Biosciences Headline on 19th of July 2024

Filed transaction by IGM Biosciences Officer: Chief Business Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Cerevel Therapeutics Valuation on July 21, 2024

It is possible to determine the worth of Cerevel Therapeutics on a given historical date. On July 21, 2024 Cerevel was worth 42.74 at the beginning of the trading date compared to the closed value of 42.9. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cerevel Therapeutics stock. Still, in general, we apply an absolute valuation method to find Cerevel Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cerevel Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cerevel Therapeutics' related companies.
 Open High Low Close Volume
  42.50    43.10    42.50    42.70    2,626,126  
07/19/2024
  42.74    42.91    42.53    42.90    2,241,590  
  43.13    43.61    43.13    43.44    2,197,746  
Backtest Cerevel Therapeutics  |  Cerevel Therapeutics History  |  Cerevel Therapeutics Valuation   PreviousNext  
Open Value
42.74
42.9
Closing Value
42.74
Upside

Cerevel Therapeutics Trading Date Momentum on July 21, 2024

On July 22 2024 Cerevel Therapeutics Holdings was traded for  43.44  at the closing time. The top price for the day was 43.61  and the lowest listed price was  43.13 . The trading volume for the day was 2.2 M. The trading history from July 22, 2024 was a factor to the next trading day price growth. The overall trading delta against the next closing price was 1.26% . The overall trading delta against the current closing price is 3.99% .

Cerevel Therapeutics Fundamentals Correlations and Trends

By evaluating Cerevel Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cerevel Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cerevel financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cerevel Therapeutics Stock history

Cerevel Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cerevel is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cerevel Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cerevel Therapeutics stock prices may prove useful in developing a viable investing in Cerevel Therapeutics
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts. Cerevel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 258 people.

Cerevel Therapeutics Stock Technical Analysis

Cerevel Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Cerevel Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cerevel Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cerevel Therapeutics Period Price Range

Low
December 11, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Cerevel Therapeutics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cerevel Therapeutics December 11, 2024 Market Strength

Market strength indicators help investors to evaluate how Cerevel Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cerevel Therapeutics shares will generate the highest return on investment. By undertsting and applying Cerevel Therapeutics stock market strength indicators, traders can identify Cerevel Therapeutics Holdings entry and exit signals to maximize returns

Cerevel Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cerevel Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Cerevel Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cerevel to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Consideration for investing in Cerevel Stock

If you are still planning to invest in Cerevel Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cerevel Therapeutics' history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities